Literature DB >> 8191763

Hormonal therapy for metastatic prostate cancer.

E J Small.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8191763      PMCID： PMC1022396     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  3 in total

1.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

Authors:  E D Crawford; M A Eisenberger; D G McLeod; J T Spaulding; R Benson; F A Dorr; B A Blumenstein; M A Davis; P J Goodman
Journal:  N Engl J Med       Date:  1989-08-17       Impact factor: 91.245

Review 2.  Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy.

Authors:  F Labrie; A Belanger; J Simard; C Labrie; A Dupont
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

3.  Basis for hormonal management of advanced prostate cancer.

Authors:  J Geller
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.